Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
2019
Purpose
To investigate the efficacy of metformin (M) plus chemotherapy versus chemotherapy alone in metastatic breast cancer (MBC).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
38
Citations
NaN
KQI